[1]
F. Mehmood, M. Zeeshan, M. Umair, N. Khan, A. A. Wajid, and A. Ali, “IMATINIB IN CHRONIC MYELOID LEUKEMIA: PATIENT-REPORTED SIDE EFFECTS AND THEIR INFLUENCE ON QUALITY OF LIFE: Imatinib in Chronic Myeloid Leukemia”, Pak Armed Forces Med J, vol. 68, no. 3, pp. 466–70, Oct. 2018, Accessed: Oct. 06, 2024. [Online]. Available: https://pafmj.org/PAFMJ/article/view/245